CORE--TISSUE ACQUISITION AND CELL CULTURE
核心——组织采集和细胞培养
基本信息
- 批准号:6202603
- 负责人:
- 金额:$ 18.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-09-01 至 2000-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Basic research toward understanding the pathobiology of cystic fibrosis
requires a continuing and dependable source of cells, affected and
unaffected by the disease. Thus, the primary objective of the Core Cell
Culture Facility is to acquire airway tissues and culture airway surface
epithelial and tracheobronchial gland cells. A tissue procurement system
has been established for obtaining normal and cystic fibrosis airway
tissue. Once obtained, surface epithelial tissue is enzymatically digested
and liberated cells are established in primary culture. Tracheobronchial
gland cells are isolated as acini and expanded through a single passage.
Surface epithelial and gland cell cultures are evaluated for
differentiated properties using light microscopy, electron microscopy and
measurements of short circuit current and transpithelial resistance. Cells
showings satisfactory features are distributed to investigators. If
surplus cells are available, these are frozen for use later. Additionally,
established cell lines routinely used by investigators are maintained in
the Core Cell Culture Facility. The final aim of the Cell Culture Core
Facility is to continue efforts to improve cultures, particularly those
derived from tracheobronchial gland cells and to develop cell culture
model systems applicable to the studies proposed by SCOR investigators.
With respect to improving in vitro cell differentiation, both soluble
factors (growth factors, hormones, chemicals) added to culture medium and
insoluble factors (extracellular matrix components, air interface culture)
are tested for their effects on airway gland cell growth and
differentiation. Culture conditions that allow full expression of ion
transport and mucus secretory function are two of the goals of this aim.
However, the highest priority will be given to determining the culture
conditions that promote serous gland cell differentiation.
了解囊性纤维化病理生物学的基础研究
需要持续和可靠的细胞来源,受影响和
没有受到这种疾病的影响。因此,核心单元的主要目标是
培养设施是获取呼吸道组织和培养呼吸道表面
上皮和气管支气管腺细胞。一种纸巾采购系统
已经建立了获得正常和囊性纤维化气道的方法
组织。一旦获得表面上皮组织,就会被酶消化
并在原代培养中建立了解放细胞。气管、支气管镜
腺细胞被分离成腺泡,并通过单个通道扩张。
对表面上皮细胞和腺体细胞培养进行评估
利用光学显微镜、电子显微镜和
短路电流和跨上皮阻力的测量。单元格
令人满意的特征被分发给调查人员。如果
多余的细胞是可用的,这些细胞被冷冻起来供以后使用。另外,
研究人员常规使用的已建立的细胞系在
核心细胞培养设施。细胞培养核心的最终目标
设施是继续努力改善文化,特别是那些
从气管、支气管腺细胞中提取细胞并进行细胞培养
适用于SCOR调查人员提出的研究的示范系统。
关于促进体外细胞分化,两者都可
添加到培养基中的因子(生长因子、激素、化学物质)和
不溶性因素(细胞外基质成分、空气界面培养)
测试它们对呼吸道腺体细胞生长的影响
差异化。允许充分表达离子的培养条件
转运和粘液分泌功能是这一目标的两个目标。
但是,最优先考虑的将是确定区域性
促进浆液腺细胞分化的条件。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WALTER E FINKBEINER其他文献
WALTER E FINKBEINER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WALTER E FINKBEINER', 18)}}的其他基金
STUDIES OF AIRWAY SUBMUCOSAL GLANDS AND EPITHELIAL CELLS
气道粘膜下腺和上皮细胞的研究
- 批准号:
3081826 - 财政年份:1984
- 资助金额:
$ 18.09万 - 项目类别:
STUDIES OF AIRWAY SUBMUCOSAL GLANDS AND EPITHELIAL CELLS
气道粘膜下腺和上皮细胞的研究
- 批准号:
3081827 - 财政年份:1984
- 资助金额:
$ 18.09万 - 项目类别:
STUDIES OF AIRWAY SUBMUCOSAL GLANDS AND EPITHELIAL CELLS
气道粘膜下腺和上皮细胞的研究
- 批准号:
3081824 - 财政年份:1984
- 资助金额:
$ 18.09万 - 项目类别:
STUDIES OF AIRWAY SUBMUCOSAL GLANDS AND EPITHELIAL CELLS
气道粘膜下腺和上皮细胞的研究
- 批准号:
3081825 - 财政年份:1984
- 资助金额:
$ 18.09万 - 项目类别:
相似海外基金
Rapid detection of Pseudomonas aeruginosa in people with cystic fibrosis
快速检测囊性纤维化患者中的铜绿假单胞菌
- 批准号:
10103495 - 财政年份:2024
- 资助金额:
$ 18.09万 - 项目类别:
Collaborative R&D
Rational optimization of combinatorial therapies for the treatment of rare cystic fibrosis variants
合理优化治疗罕见囊性纤维化变异的组合疗法
- 批准号:
10736732 - 财政年份:2023
- 资助金额:
$ 18.09万 - 项目类别:
Pulmonary delivery of base editors for gene therapy of cystic fibrosis with nonsense mutations
肺部递送碱基编辑器用于无义突变囊性纤维化的基因治疗
- 批准号:
488681 - 财政年份:2023
- 资助金额:
$ 18.09万 - 项目类别:
Operating Grants
Analysis of synthetic derivatives with reduced lipophilicity as candidate potentiators towards better treatment alternatives for Cystic Fibrosis
分析亲脂性降低的合成衍生物作为候选增效剂,以获得更好的囊性纤维化治疗替代方案
- 批准号:
481159 - 财政年份:2023
- 资助金额:
$ 18.09万 - 项目类别:
Developing Gene Editing Therapeutics, Biodegradable Polymeric Delivery Vehicles, and High-throughput Platforms for the Treatment of Cystic Fibrosis
开发用于治疗囊性纤维化的基因编辑疗法、可生物降解的聚合物递送载体和高通量平台
- 批准号:
10836095 - 财政年份:2023
- 资助金额:
$ 18.09万 - 项目类别:
A Ginsenoside TMEM16A Potentiator for Cystic Fibrosis
人参皂苷 TMEM16A 治疗囊性纤维化的增效剂
- 批准号:
10574384 - 财政年份:2023
- 资助金额:
$ 18.09万 - 项目类别:
Computationally-Inspired Design of Non-Viral Gene Delivery Vehicles for mRNA-Based Cystic Fibrosis Therapies
用于基于 mRNA 的囊性纤维化治疗的非病毒基因传递载体的计算启发设计
- 批准号:
10760605 - 财政年份:2023
- 资助金额:
$ 18.09万 - 项目类别:
Health Outcomes of Parents with Cystic Fibrosis (HOPe:CF)
患有囊性纤维化的父母的健康结果 (HOPe:CF)
- 批准号:
10581321 - 财政年份:2023
- 资助金额:
$ 18.09万 - 项目类别:
Preparation for lung transplant discussions and decisions among people with cystic fibrosis
囊性纤维化患者肺移植讨论和决策的准备
- 批准号:
10657027 - 财政年份:2023
- 资助金额:
$ 18.09万 - 项目类别:
The role of anaerobic microbiota in cystic fibrosis airway disease trajectory
厌氧微生物群在囊性纤维化气道疾病轨迹中的作用
- 批准号:
10716654 - 财政年份:2023
- 资助金额:
$ 18.09万 - 项目类别: